Cost-Effectiveness Analysis of Ingenolo Mebutato Verse Imiquimod in the Treatment of Actinic Keratoses in the Perspective of the Italian Health System
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2126
https://www.valueinhealthjournal.com/article/S1098-3015(14)04056-X/fulltext
Title :
Cost-Effectiveness Analysis of Ingenolo Mebutato Verse Imiquimod in the Treatment of Actinic Keratoses in the Perspective of the Italian Health System
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04056-X&doi=10.1016/j.jval.2014.08.2126
First page :
A608
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1590